Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Benner

Showing results (161-170 of 347) with videos related to

Pageof 35
Sort By:
Genomics|October 11, 2015
Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapyKatrin Pfütze, Axel Benner, Michael Hoffmeister, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2003
Personal characteristics, therapy modalities and individual DNA repair capacity as predictive factors of acute skin toxicity in an unselected cohort of breast cancer patients receiving radiotherapyDorothee Twardella, Odilia Popanda, Irmgard Helmbold, et al.
Cancer Letters|November 29, 2012
MYCN-mediated overexpression of mitotic spindle regulatory genes and loss of p53-p21 function jointly support the survival of tetraploid neuroblastoma cellsSina Gogolin, Richa Batra, Nathalie Harder, et al.
Plos One|March 28, 2015
Mismatch repair-deficient crypt foci in Lynch syndrome--molecular alterations and association with clinical parametersLaura Staffa, Fabian Echterdiek, Nina Nelius, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastomaFrank Mendrzyk, Bernhard Radlwimmer, Stefan Joos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2015
Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimensTilmann Bochtler, Ute Hegenbart, Christina Kunz, et al.
Cancers|July 24, 2021
Antibiotic Prophylaxis or Granulocyte-Colony Stimulating Factor Support in Multiple Myeloma Patients Undergoing Autologous Stem Cell TransplantationEva-Maria Klein, Sandra Sauer, Sabrina Klein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patientsKai-Oliver Henrich, Matthias Fischer, Daniel Mertens, et al.
Haematologica|December 3, 2009
Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemiaDirk Kienle, Axel Benner, Carolin Läufle, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 25, 2005
Haplotype analysis of the COMT-ARVCF gene region in Israeli anorexia nervosa family triosElena Michaelovsky, Amos Frisch, Shani Leor, et al.
Pageof 35

Showing results (161-170 of 347) with videos related to

Sort By:
Pageof 35
Genomics|October 11, 2015
Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapyKatrin Pfütze, Axel Benner, Michael Hoffmeister, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 4, 2003
Personal characteristics, therapy modalities and individual DNA repair capacity as predictive factors of acute skin toxicity in an unselected cohort of breast cancer patients receiving radiotherapyDorothee Twardella, Odilia Popanda, Irmgard Helmbold, et al.
Cancer Letters|November 29, 2012
MYCN-mediated overexpression of mitotic spindle regulatory genes and loss of p53-p21 function jointly support the survival of tetraploid neuroblastoma cellsSina Gogolin, Richa Batra, Nathalie Harder, et al.
Plos One|March 28, 2015
Mismatch repair-deficient crypt foci in Lynch syndrome--molecular alterations and association with clinical parametersLaura Staffa, Fabian Echterdiek, Nina Nelius, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastomaFrank Mendrzyk, Bernhard Radlwimmer, Stefan Joos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2015
Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimensTilmann Bochtler, Ute Hegenbart, Christina Kunz, et al.
Cancers|July 24, 2021
Antibiotic Prophylaxis or Granulocyte-Colony Stimulating Factor Support in Multiple Myeloma Patients Undergoing Autologous Stem Cell TransplantationEva-Maria Klein, Sandra Sauer, Sabrina Klein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patientsKai-Oliver Henrich, Matthias Fischer, Daniel Mertens, et al.
Haematologica|December 3, 2009
Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemiaDirk Kienle, Axel Benner, Carolin Läufle, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|August 25, 2005
Haplotype analysis of the COMT-ARVCF gene region in Israeli anorexia nervosa family triosElena Michaelovsky, Amos Frisch, Shani Leor, et al.
Pageof 35